Fabrice Chouraqui

Fabrice Chouraqui, CEO of Cellarity and a leader in biotech innovation, shares insights on the transformative role of AI in drug discovery. He discusses the shift from isolated targets to addressing cellular dysfunctions and the importance of machine learning in overcoming traditional challenges. Fabrice emphasizes the necessity of collaboration and a strong organizational culture for fostering innovation. He also envisions a future where AI reduces drug failure rates, making groundbreaking treatments more accessible to patients.